Live-cell imaging of cell-to-cell variability in caspase-8 FRET reporter activity and cell fate trajectory modeling - Dataset (ID:20232)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein | Protein Concentration | Protein Conc Unit | Antibody Name | Antibody Concentration | Antibody Conc Unit | 2nd Antibody Name | 2nd Antibody Concentration | 2nd Antibody Conc Unit | Replicate | Mean log10(k) (a.u.) | Mean tau (min) | Surviving Fraction | Classification Accuracy (theta_T) | Classification Accuracy (fate boundary) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HeLa ICRP | Apomab | 25.0 | nM | 4 | -6.67 | 260.1646 | 0.889 | 0.89300 | 0.83951 | |||||||||
| HeLa ICRP | Apomab | 25.0 | nM | 6 | -6.53 | 267.1805 | 0.838 | 0.85338 | 0.84962 | |||||||||
| HeLa ICRP | Apomab | 25.0 | nM | 1 | -6.44 | 211.4919 | 0.968 | 0.97581 | 0.75806 | |||||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 4 | -6.21 | 485.6552 | 0.814 | 0.97069 | 0.80517 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 5 | -6.05 | 472.6445 | 0.683 | 0.94218 | 0.72805 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 5 | -6.31 | 302.5813 | 0.872 | 0.90672 | 0.84816 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 1 | -5.30 | 298.2392 | 0.073 | 0.94086 | 0.48387 | |||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 2 | -5.36 | 315.9300 | 0.077 | 0.87923 | 0.49275 | |||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 5 | -5.44 | 331.4063 | 0.076 | 0.91071 | 0.41295 | |||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 4 | -6.12 | 272.4815 | 0.907 | 0.92963 | 0.88889 | ||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | anti-Fc | 25.0 | nM | 1 | -4.50 | 85.1585 | 0.268 | 0.73592 | 0.70775 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 1 | -6.20 | 481.7639 | 0.801 | 0.96817 | 0.78780 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 2 | -5.70 | 239.2890 | 0.839 | 0.94037 | 0.83028 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 2 | -5.39 | 331.3306 | 0.083 | 0.86694 | 0.49064 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 1 | -5.57 | 236.0268 | 0.848 | 0.90179 | 0.77679 | ||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | 3 | -5.13 | 188.8499 | 0.479 | 0.88378 | 0.76029 | |||||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | 1 | -5.21 | 212.5904 | 0.659 | 0.86345 | 0.76707 | |||||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | 2 | -4.77 | 139.4757 | 0.442 | 0.77528 | 0.66667 | |||||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 6 | -5.73 | 240.3203 | 0.808 | 0.91922 | 0.84401 | ||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | anti-Fc | 25.0 | nM | 2 | -4.55 | 92.1239 | 0.381 | 0.66372 | 0.64307 | ||||||
| HeLa ICRP | Mapatumumab | 25.0 | nM | anti-Fc | 25.0 | nM | 3 | -4.54 | 92.8286 | 0.238 | 0.83860 | 0.78369 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 3 | -6.52 | 286.1860 | 0.876 | 0.88410 | 0.86523 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 3 | -6.35 | 445.1084 | 0.889 | 0.98103 | 0.88889 | ||||||
| HeLa ICRP | Apomab | 50.0 | nM | 1 | -6.39 | 285.0388 | 0.953 | 0.95349 | 0.85271 | |||||||||
| HeLa ICRP | Apomab | 50.0 | nM | 2 | -6.48 | 250.9659 | 0.972 | 0.98864 | 0.80682 |